.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Phas3 is stocked at 64 licensed dispensaries across Maryland, with the deepest coverage in Baltimore, Annapolis, Rockville, Cockeysville, and Columbia. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Phas3 concentrated 71.83% of sales in Flower with a 290.65% year-over-year increase while posting a 3.58% month-over-month decline, indicating mix stability but near-term softening; Pre-Roll held 19.31% share with 86.94% YoY growth and a 13.46% MoM gain, suggesting incremental contribution offsetting Flower’s dip. Concentrates accounted for 5.93% share with a 755.66% YoY surge but a 25.68% MoM pullback, whereas Vapor Pens at 2.93% share rose 333.70% YoY and 28.79% MoM; together these shifts imply the brand is expanding beyond Flower into faster-growing, smaller formats that cushion volatility while average price rising 28.86% YoY pairs with mixed MoM outcomes to signal elasticity differences by category.
Phas3’s reliance on Flower at 71.83% share alongside a rank of 27 in Flower in Maryland points to mid-pack visibility where MoM softness in Flower (down 3.58%) is being counterbalanced by Pre-Roll and Vapor Pens (up 13.46% and 28.79% MoM, respectively), implying a tilt toward trial-friendly and convenience formats to drive incremental baskets. The juxtaposition of triple-digit YoY gains in Concentrates (755.66%) with a steep MoM decline (down 25.68%) and stable growth in Pre-Roll (86.94% YoY) suggests Phas3’s near-term positioning benefits from breadth, but sustained share lift likely depends on converting novelty spikes into repeat via pricing around the $19.46 brand average and leveraging Vapor Pens’ 333.70% YoY surge to diversify away from single-category risk.
Competitive Landscape
Phas3 sits at rank #27 in September 2026, up 14 positions year over year from #41, but only 9 positions ahead of its June 2026 mark of #36, indicating a slower recent climb; its best placement to date was #26 in October 2025, so the current slot is one rank off peak while the market leader SunMed held #1 both year over year and currently with an 11.8% sales increase, and Strane advanced from #10 to #5 with 46.0% sales growth, outpacing Phas3’s rank momentum. This pattern implies Phas3’s trajectory is improving on a yearly basis but losing relative ground to faster-advancing rivals, so sustaining gains will likely require converting the incremental year-over-year lift into month-over-month rank wins.
Notable Products
Jack Herer Pre-Roll 2-Pack (1g) posted the largest month-over-month surge at +50.2% while holding rank 6, contrasting with Acapulco Gold (3.5g) which fell -18.9% at rank 10. Pineapple Express (3.5g) grew +28.4% to rank 1, and Jack Herer (3.5g) advanced +48.5% at rank 3. With four of the top ten coming from Flower and four from Pre-Roll, the mix tilts toward formats that can be cross-promoted under overlapping strain names, implying a push to pair high-velocity eighths with matching two-pack pre-rolls for basket expansion.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
